2.21
price down icon0.90%   -0.02
after-market Handel nachbörslich: 2.25 0.04 +1.81%
loading
Schlusskurs vom Vortag:
$2.23
Offen:
$2.23
24-Stunden-Volumen:
99,539
Relative Volume:
0.43
Marktkapitalisierung:
$165.25M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-23.96M
KGV:
-1.8889
EPS:
-1.17
Netto-Cashflow:
$-21.05M
1W Leistung:
-1.34%
1M Leistung:
+15.10%
6M Leistung:
+19.46%
1J Leistung:
+76.80%
1-Tages-Spanne:
Value
$2.14
$2.259
1-Wochen-Bereich:
Value
$2.125
$2.3257
52-Wochen-Spanne:
Value
$0.77
$2.75

Context Therapeutics Inc Stock (CNTX) Company Profile

Name
Firmenname
Context Therapeutics Inc
Name
Telefon
267-225-7416
Name
Adresse
2001 MARKET STREET, PHILADELPHIA
Name
Mitarbeiter
9
Name
Twitter
Name
Nächster Verdiensttermin
Name
Neueste SEC-Einreichungen
Name
CNTX's Discussions on Twitter

Context Therapeutics Inc Aktie (CNTX) Neueste Nachrichten

pulisher
11:00 AM

Protect Your Health: Discover the Life-Saving Potential of Early Lung Cancer Screenings at Local Hospitals - MyChesCo

11:00 AM
pulisher
Nov 04, 2024

HR+ HER2-ve Breast Cancer Pipeline Therapeutics, Assessment, Companies, Products, Unmet Needs, Market Drivers and Barriers - The Globe and Mail

Nov 04, 2024
pulisher
Nov 04, 2024

HR+ HER2-ve Breast Cancer Pipeline Therapeutics, Assessment, - openPR

Nov 04, 2024
pulisher
Nov 04, 2024

West Pharmaceutical Services Announces Upcoming Conference Presentations - MyChesCo

Nov 04, 2024
pulisher
Oct 28, 2024

Windtree Therapeutics announces $27.24 million equity sale option - Investing.com

Oct 28, 2024
pulisher
Oct 27, 2024

Spero Therapeutics, Inc. (NASDAQ:SPRO) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap? - Yahoo Finance

Oct 27, 2024
pulisher
Oct 26, 2024

Institutions along with retail investors who hold considerable shares inSeres Therapeutics, Inc. (NASDAQ:MCRB) come under pressure; lose 17% of holdings value - Simply Wall St

Oct 26, 2024
pulisher
Oct 25, 2024

Context Therapeutics to Engage Investors at November Conferences - MyChesCo

Oct 25, 2024
pulisher
Oct 23, 2024

Intensity Therapeutics grants stock options to top executives - Investing.com

Oct 23, 2024
pulisher
Oct 23, 2024

Context Therapeutics Inc (NASDAQ: CNTX) Gains 14.50% In Early Trade; What Lies Ahead? - Stocks Register

Oct 23, 2024
pulisher
Oct 23, 2024

Context Therapeutics to Participate in Upcoming Investor Conferences in November - GlobeNewswire

Oct 23, 2024
pulisher
Oct 22, 2024

Tolerance Bio Secures $17.2 Million to Advance Immune Disease Therapies - MyChesCo

Oct 22, 2024
pulisher
Oct 21, 2024

Er +/Her2 -Ve Breast Cancer Pipeline 2024: Clinical Trials - openPR

Oct 21, 2024
pulisher
Oct 17, 2024

Context Therapeutics to Showcase Promising Cancer Therapy at SITC Annual Meeting - MSN

Oct 17, 2024
pulisher
Oct 16, 2024

Alcura Secures MIA License to Enhance Cell and Gene Therapy Importation - MSN

Oct 16, 2024
pulisher
Oct 16, 2024

Context Therapeutics Announces Poster Presentation at the - GlobeNewswire

Oct 16, 2024
pulisher
Oct 16, 2024

Context Therapeutics Announces Poster Presentation at the Society for Immunotherapy of Cancer’s (SITC) 39th Annual Meeting - StockTitan

Oct 16, 2024
pulisher
Oct 15, 2024

LVMH shows good resilience in the current context - Yahoo Finance

Oct 15, 2024
pulisher
Oct 15, 2024

Unpacking Q2 Earnings: Keysight (NYSE:KEYS) In The Context Of Other Inspection Instruments Stocks - Yahoo Finance

Oct 15, 2024
pulisher
Oct 14, 2024

Unpacking Q2 Earnings: Vulcan Materials (NYSE:VMC) In The Context Of Other Building Materials Stocks - Yahoo Finance

Oct 14, 2024
pulisher
Oct 14, 2024

Unpacking Q2 Earnings: Flywire (NASDAQ:FLYW) In The Context Of Other Finance and HR Software Stocks - Yahoo Finance

Oct 14, 2024
pulisher
Oct 14, 2024

Genelux Co. (NASDAQ:GNLX) Shares Sold by Renaissance Technologies LLC - Defense World

Oct 14, 2024
pulisher
Oct 11, 2024

Both private equity firms who control a good portion of Context Therapeutics Inc. (NASDAQ:CNTX) along with institutions must be dismayed after last week's 14% decrease - Simply Wall St

Oct 11, 2024
pulisher
Oct 09, 2024

Bentley Systems Partners with Google to Bring Powerful Geospatial Context and Capabilities to Infrastructure - Yahoo Finance

Oct 09, 2024
pulisher
Oct 08, 2024

Virios Therapeutics shares target raised on Wex merger news - Investing.com

Oct 08, 2024
pulisher
Oct 07, 2024

What was Context Therapeutics Inc (CNTX)’s performance in the last session? - US Post News

Oct 07, 2024
pulisher
Oct 07, 2024

BioAtla: Numerous Catalysts Coming In Q4 (NASDAQ:BCAB) - Seeking Alpha

Oct 07, 2024
pulisher
Oct 07, 2024

BioAtla to Score Up to $133M - San Diego Business Journal

Oct 07, 2024
pulisher
Oct 07, 2024

Unpacking Q2 Earnings: Topgolf Callaway (NYSE:MODG) In The Context Of Other Leisure Facilities Stocks - Yahoo Finance

Oct 07, 2024
pulisher
Oct 06, 2024

BioAtla to Host Virtual R&D Day on Clinical Program and Pipeline Updates on July 25, 2024 - Quantisnow

Oct 06, 2024
pulisher
Oct 04, 2024

CNTX’s Stock Market Adventure: 75.22% YTD Growth Amidst Volatility - The InvestChronicle

Oct 04, 2024
pulisher
Oct 04, 2024

Context Therapeutics To Make Nasdaq Debut Today - RTTNews

Oct 04, 2024
pulisher
Oct 02, 2024

Context Therapeutics Inc (CNTX) deserves closer scrutiny - US Post News

Oct 02, 2024
pulisher
Oct 02, 2024

Deal Watch: Shionogi Will Market Nxera’s Insomnia Drug In Japan - Scrip

Oct 02, 2024
pulisher
Oct 01, 2024

Nantahala Capital Management LLC Purchases New Position in Context Therapeutics Inc. (NASDAQ:CNTX) - MarketBeat

Oct 01, 2024
pulisher
Oct 01, 2024

Unpacking Q2 Earnings: Otis (NYSE:OTIS) In The Context Of Other General Industrial Machinery Stocks - Yahoo Finance

Oct 01, 2024
pulisher
Sep 30, 2024

Ratios Reveal: Breaking Down Context Therapeutics Inc (CNTX)’s Financial Health - The Dwinnex

Sep 30, 2024
pulisher
Sep 30, 2024

Driehaus Capital Management LLC Purchases Shares of 2,258,065 Context Therapeutics Inc. (NASDAQ:CNTX) - MarketBeat

Sep 30, 2024
pulisher
Sep 30, 2024

Unpacking Q2 Earnings: Arlo (NYSE:ARLO) In The Context Of Other Internet of Things Stocks - Yahoo Finance

Sep 30, 2024
pulisher
Sep 28, 2024

Blue Owl Capital Holdings LP Takes Position in Context Therapeutics Inc. (NASDAQ:CNTX) - MarketBeat

Sep 28, 2024
pulisher
Sep 27, 2024

Century Therapeutics Announces Strategic Leadership Appointments - MyChesCo

Sep 27, 2024
pulisher
Sep 27, 2024

Unpacking Q2 Earnings: Winnebago (NYSE:WGO) In The Context Of Other Automobile Manufacturers Stocks - Yahoo Finance

Sep 27, 2024
pulisher
Sep 26, 2024

Q3 2024 EPS Estimates for Context Therapeutics Inc. Reduced by HC Wainwright (NASDAQ:CNTX) - MarketBeat

Sep 26, 2024
pulisher
Sep 26, 2024

BioAtla and Context Therapeutics Forge Strategic Agreement for Cancer Treatment Development - MSN

Sep 26, 2024
pulisher
Sep 25, 2024

Affinity Asset Advisors LLC Sells 233,000 Shares of Mersana Therapeutics, Inc. (NASDAQ:MRSN) - Defense World

Sep 25, 2024
pulisher
Sep 25, 2024

Affinity Asset Advisors LLC Has $3.25 Million Stock Position in Context Therapeutics Inc. (NASDAQ:CNTX) - MarketBeat

Sep 25, 2024
pulisher
Sep 24, 2024

Great Point Partners LLC Makes New Investment in Context Therapeutics Inc. (NASDAQ:CNTX) - MarketBeat

Sep 24, 2024
pulisher
Sep 24, 2024

Ally Bridge Group NY LLC Grows Stock Holdings in Context Therapeutics Inc. (NASDAQ:CNTX) - MarketBeat

Sep 24, 2024
pulisher
Sep 24, 2024

Context Therapeutics’ (CNTX) “Buy” Rating Reaffirmed at HC Wainwright - Defense World

Sep 24, 2024
pulisher
Sep 24, 2024

BioAtla out-licenses T cell therapy in $134 million deal - The Pharma Letter

Sep 24, 2024
pulisher
Sep 23, 2024

BioAtla licenses cancer drug candidate to Context Therapeutics By Investing.com - Investing.com Canada

Sep 23, 2024

Finanzdaten der Context Therapeutics Inc-Aktie (CNTX)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$77.28
price up icon 2.02%
$20.39
price up icon 2.15%
$382.77
price up icon 1.58%
$53.29
price down icon 0.47%
$208.03
price up icon 0.38%
$110.97
price up icon 1.84%
Kapitalisierung:     |  Volumen (24h):